In an immunological investigation of patients with ovarian cancer, the presence of NY‐ESO‐1 autoantibodies was associated with increased tumor‐infiltrating CD8+, CD4+, and FoxP3+ cells. Here, CD8A is linked to ovarian carcinoma.